Chimeric Therapeutics (ASX:CHM) receives overwhelming support for $35M IPO
Chimeric Therapeutics (ASX:CHM) has received overwhelming support from investors, raising $35 million via an initial public…
| Fri, 23 Jan | Last | Change |
| 2:11pm | 8,863.8 | 15.1 |
| Currently Trading at Fri, 23 Jan 2:33pm | ||
| S&P/ASX Sm. Ords. | 4,000.2 | 33.0 | 0.83% |
| All Ordinaries | 9,194.2 | 21.7 | 0.24% |
| S&P/ASX 100 | 7,329.1 | 7.20 | 0.10% |
| NME | NEX METALS EXPLORATION LIMITED | 2.5¢ | 31.6% |
| EMN | EURO MANGANESE INC | 21.5¢ | 30.3% |
| 360 | LIFE360 INC. | $33.95 | 28.0% |
| OSX | OSTEOPORE LIMITED | 2.2¢ | 18.5% |
| CDE | CODEIFAI LIMITED | 1.0¢ | 16.7% |
| AZI | ALTAMIN LIMITED | 2.3¢ | 14.8% |